Cargando…

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human

Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluation and optimization of new protocols. Spontaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etienne, Floriane, Berthaud, Maxime, Nguyen, Frédérique, Bernardeau, Karine, Maurel, Catherine, Bodet-Milin, Caroline, Diab, Maya, Abadie, Jérôme, Gouilleux-Gruart, Valérie, Vidal, Aurélien, Bourgeois, Mickaël, Chouin, Nicolas, Ibisch, Catherine, Davodeau, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018706/ https://www.ncbi.nlm.nih.gov/pubmed/32117707 http://dx.doi.org/10.3389/fonc.2020.00020

Ejemplares similares

Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
por: Dorso, Laëtitia, et al.
Publicado: (2016)

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
por: Rousseau, Caroline, et al.
Publicado: (2011)

Comparison of Immuno-PET of CD138 and PET imaging with (64)CuCl(2) and (18)F-FDG in a preclinical syngeneic model of multiple myeloma
por: Bailly, Clément, et al.
Publicado: (2018)

What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between (89)Zr- and (64)Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model
por: Bailly, Clément, et al.
Publicado: (2019)

Oxidative metabolism in cancer: A STAT affair?
por: Bourgeais, Jérome, et al.
Publicado: (2013)

Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
por: Nguyen, Frédérique, et al.
Publicado: (2017)

Immuno-PET: Design options and clinical proof-of-concept
por: Lugat, Alexandre, et al.
Publicado: (2022)

Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture
por: Bailly, Clément, et al.
Publicado: (2019)

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
por: Fichou, Nolwenn, et al.
Publicado: (2015)

Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
por: Abadie, Jérôme, et al.
Publicado: (2017)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma
por: Jamet, Bastien, et al.
Publicado: (2020)

FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?
por: Michaud-Robert, Anne-Victoire, et al.
Publicado: (2020)

Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020)

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
por: Bailly, Clément, et al.
Publicado: (2019)

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
por: Gouard, Sébastien, et al.
Publicado: (2020)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
por: Ramdani, Yanis, et al.
Publicado: (2022)

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients
por: Bailly, Clément, et al.
Publicado: (2017)

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation
por: Meley, Daniel, et al.
Publicado: (2017)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

“Ways in which the neonatal Fc-receptor is involved in autoimmunity”
por: Lamamy, Juliette, et al.
Publicado: (2021)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
por: Dumet, Christophe, et al.
Publicado: (2023)

The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI
por: Bernsen, Monique R., et al.
Publicado: (2014)

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials
por: Bailly, Clément, et al.
Publicado: (2016)

Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
por: Pallardy, Amandine, et al.
Publicado: (2020)

Sensitivity of pretargeted immunoPET using (68)Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with (18)FDG PET-CT
por: Foubert, Fanny, et al.
Publicado: (2018)

Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
por: Lamendour, Lucille, et al.
Publicado: (2020)

Tumor Immunotargeting Using Innovative Radionuclides
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Preclinical properties and human in vivo assessment of (123) I-ABC577 as a novel SPECT agent for imaging amyloid-β
por: Maya, Yoshifumi, et al.
Publicado: (2016)

(64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study
por: Pérès, Elodie A., et al.
Publicado: (2019)

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
por: Bodet-Milin, Caroline, et al.
Publicado: (2019)

The neonatal Fc receptor expression during macrophage differentiation is related to autophagy
por: Lamamy, Juliette, et al.
Publicado: (2022)

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
por: DeBay, Drew R., et al.
Publicado: (2017)

Performance Evaluation of a Preclinical SPECT Scanner with a Collimator Designed for Medium-Sized Animals
por: Matsusaka, Yohji, et al.
Publicado: (2022)

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction
por: Ménager, Jérémie, et al.
Publicado: (2015)

Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability
por: Bailly, Matthieu, et al.
Publicado: (2023)

Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments
por: Prieto, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2int7fc0hieot4u3echon8t3p